 Bull World Health Organ 2018;96:129–134 | doi: http://dx.doi.org/10.2471/BLT.17.199588
Policy & practice
129
Pandemic risk: how large are the expected losses?
Victoria Y Fan,a Dean T Jamisonb & Lawrence H Summersc
Introduction
Few doubt that major epidemics and pandemics will strike again 
and few would argue that the world is adequately prepared. Since 
the 2013–2016 Ebola virus disease outbreak in western Africa, 
the United States National Academy of Medicine1 and several 
other groups2–4 have pointed to gaps, and the need for greater 
investment, in preparation against epidemics and pandemics, 
of Ebola virus disease and other infectious diseases. Attempts 
to justify greater investment have mostly been based on esti-
mates of the industrial and macroeconomic losses attributable 
to influenza pandemics.5–11 We have recently extended the loss 
assessment to include a valuation of the lives lost as a result of the 
increases in mortality resulting from influenza-pandemic risk.12 
The inclusion of such a valuation increased the estimated loss 
attributable to modelled pandemic risk several fold. Below, we 
discuss our method and summarize our findings. Box 1 presents 
the definition of several of the terms we are using in this paper.
Valuing lives
Most previous economic studies on global influenza pandem-
ics have focused on income losses, through reductions in the 
size of the labour force and productivity, increases in absen-
teeism and, importantly, as the result of individual and social 
measures that interrupt transmission, but disrupt economic 
activity. While measures such as the per-capita gross national 
income include the effect of pandemics on income, they also 
exclude the value of changes in mortality risk to individuals. If, 
in assessments of investments in pandemic preparedness and 
mitigation, we neglect this dimension of loss, we will under-
estimate the value of such investments, relative to alternative 
uses of public finances.
The broader approach that we recently applied, to the 
assessment of economic losses attributable to pandemic in-
fluenza, factors in the intrinsic loss associated with increases 
in mortality.12 In effect, this approach assigns a dollar value to 
small changes in mortality probabilities, using values derived 
from empirical studies of how individuals and societies actu-
ally value changes in mortality risk.13–16 This approach has 
already been employed extensively in environmental econom-
ics13,14 and has also been used in global health, by The Lancet 
Commission on Investing in Health.15,16
Past literature
Economic losses from influenza
We searched Google Scholar and PubMed® for studies on the 
economic losses from influenza. Almost all of the previous 
studies examined economic losses in terms of income and 
ignored the value of, and the loss associated with, mortal-
ity risk. The World Bank, for example, generated estimates 
of global income losses under different influenza pandemic 
scenarios.10,11 It found that a pandemic of the same severity 
as the 1918 influenza pandemic might reduce global gross 
domestic product by about 5% and that the disruptive effects 
of avoiding infection would account for about 60% of that 
reduction. Another study of the consequences of a range of 
pandemic severities included an extremely severe scenario 
that would lead to income losses of over 12% of gross national 
income worldwide, including losses of over 50% of the gross 
national incomes of lower-income countries.5 We found other 
integrative estimates of the magnitude of pandemic risk in two 
partially proprietary sources.17,18
Several studies have examined specific dimensions of the 
economic impacts of annual influenza, such as direct costs, 
e.g. medical and hospitalizations costs, and indirect costs, e.g. 
lost earnings due to illness and productivity costs. There are 
examples of such studies based in the Americas,6,7,19–22 Asia8,23 
and Europe.24,25 Other models have added an estimated value 
of the intrinsic undesirability of nonfatal illness or of pan-
demic fear, as seen in the population response to severe acute 
respiratory syndrome in Asia.8 Media coverage may also lead 
populations to overreact to mild pandemics.9
Abstract There is an unmet need for greater investment in preparedness against major epidemics and pandemics. The arguments in favour of 
such investment have been largely based on estimates of the losses in national incomes that might occur as the result of a major epidemic or 
pandemic. Recently, we extended the estimate to include the valuation of the lives lost as a result of pandemic-related increases in mortality. 
This produced markedly higher estimates of the full value of loss that might occur as the result of a future pandemic. We parametrized an 
exceedance probability function for a global influenza pandemic and estimated that the expected number of influenza-pandemic-related 
deaths is about 720 000 per year. We calculated that the expected annual losses from pandemic risk to be about 500 billion United States 
dollars – or 0.6% of global income – per year. This estimate falls within – but towards the lower end of – the Intergovernmental Panel on 
Climate Change’s estimates of the value of the losses from global warming, which range from 0.2% to 2% of global income. The estimated 
percentage of annual national income represented by the expected value of losses varied by country income grouping: from a little over 
0.3% in high-income countries to 1.6% in lower-middle-income countries. Most of the losses from influenza pandemics come from rare, 
severe events.
a Office of Public Health Studies, Myron B Thompson School of Social Work, University of Hawai‘i at Mānoa, 1960 East-West Road, Honolulu, HI 96822, United States of 
America (USA).
b Institute for Global Health Sciences, University of California, San Francisco, San Francisco, USA.
c Harvard Kennedy School, Harvard University, Cambridge, USA.
Correspondence to Victoria Y Fan (email: vfan@post.harvard.edu).
(Submitted: 29 June 2017 – Revised version received: 15 October 2017 – Accepted: 21 November 2017 – Published online: 5 December 2018 )
 Bull World Health Organ 2018;96:129–134| doi: http://dx.doi.org/10.2471/BLT.17.199588
130
Policy & practice
Economic losses of pandemic risk
Victoria Y Fan et al.
We found only two articles that 
included estimates of the loss from the 
elevated mortality associated with in-
fluenza pandemics.8,19 Of the 10 studies 
included in a recent systematic literature 
review on the costs of influenza,26 only 
one19 took account of the value of mor-
tality risks.
Value of a statistical life
One strand of economic research has 
examined the intrinsic value of mortal-
ity risks, which is commonly expressed 
as the so-called value of a statistical 
life. This value is derived either from 
questionnaires that canvass how much 
compensation an individual would 
demand, to accept a small increase in 
the probability of their death,1 or from 
quantitative studies of the labour market 
that investigate the trade-offs between 
small fatality risks and income.2,27
Beyond influenza, the value of 
mortality risks has been included in 
estimating the costs of vaccine-pre-
ventable diseases28 and in evaluating the 
economic burdens posed by rheumatic 
heart disease.29 Far more studies have 
assessed the burden of specific environ-
mental risk factors.13,14
The value of a statistical life, which 
is sometimes expressed as the value of a 
standardized mortality unit (SMU), i.e. 
an increase in the annual risk of death 
of 1 in 10 000, varies by both the age and 
income of the individual involved.15,16,27 
In general, the value of mortality is 
elastic to age and to income, i.e. younger 
individuals place a higher value on 
mortality than older individuals, and 
higher-income individuals generally 
value mortality more than lower-income 
individuals. The main findings of our 
recent study appeared consistent when, 
in robustness and sensitivity checks, we 
used estimates that were unconditional 
on age and estimates with varying in-
come elasticity with respect to the value 
of mortality.12
Expected-loss framework
Given the uncertain nature of an influenza 
pandemic, in terms of both when it may 
occur and how large the mortality risks will 
be, we applied an expected-loss framework 
that accounts for the uncertainty over a 
long period of time.7 An expected-loss 
framework incorporates information on 
the risk of an uncertain event, e.g. a pan-
demic, with information on the severity 
or value of that event, e.g. the increase in 
mortality. Although it has been estimated 
that the 2013–2016 Ebola virus disease 
outbreak led to about 11 300 deaths,30 the 
death toll from a severe influenza pan-
demic might be 2500 times higher than 
this.12 In any given year, however, the risk 
of a severe influenza pandemic is much 
smaller than that of an Ebola epidemic. 
The use of an expected-loss framework 
allows policy-makers to compare the ex-
pected losses associated with events with 
relatively high annual probability, but low 
mortality, e.g. an Ebola outbreak, with 
those of events with relatively low prob-
ability but high mortality, e.g. the 1918 
influenza pandemic.
Exceedance probability function
Expected-loss frameworks are com-
monly used, by actuaries in the insur-
ance industry, to calculate the size 
of premiums, e.g. for flood or health 
insurance. To value the consequences 
of uncertain events appropriately, the 
insurance industry estimates so-called 
exceedance probability functions. These 
functions generate estimates of the prob-
ability that, over a specified time frame, 
losses from an uncertain event, e.g. an 
influenza pandemic, would exceed any 
specified level. For our analysis, we de-
veloped an exceedance probability func-
tion for a global influenza pandemic. To 
parameterize the function, we turned to 
historical data on global influenza pan-
demics since the 1700s.31–34 Six pandem-
ics in this period led to excess mortality 
rates ranging between 0.03% and 0.08% 
of world population. In 2017, this range 
would be the equivalent of between 2 
million and 6 million excess deaths glob-
ally. A modelling exercise for the insur-
ance industry concluded that the annual 
risk of an influenza outbreak on the scale 
of the 1918 pandemic lies between 0.5% 
and 1.0%.18 For more severe pandemics, 
we fitted a parametrized exceedance 
probability function to modelled data 
that had been previously reported.18,35
Model calibration
Following common practice in the in-
surance industry, we defined risk, r(s), 
in terms of the annual probability of a 
pandemic having a severity exceeding 
s SMUs and the return time for s as the 
expected number of years before a pan-
demic of at least severity s will occur. If 
t(s) is the return time, then t(s) = r(s)−1. 
For example, if the annual probability of 
a pandemic of severity at least s is 1%, 
then its return time will be 100 years.
If we had access to a function r(s) 
showing exceedance probability as a 
function of severity, our analysis could 
proceed using the expected value of 
severity of all pandemics. Because r(s) 
is the complementary cumulative of the 
density for s, we would have expected 
value of:
Expected value of s =∫  r(s) d(s) 
(1)
We calibrated this model using 
historical estimates of the frequency 
and severity of influenza pandemics, 
which we obtained from our literature 
search on PubMed® and Google Scholar. 
For mortality data relating to the 1918 
influenza pandemic, we also searched 
the libraries at Harvard University and 
the University of Hawai‘i for historical 
documents and life tables. Studies were 
restricted to those with abstracts in 
English.
Box 1. Definition of terms used in this article
Loss
The consequences of a pandemic, in terms of lost income or lost lives.
Costs
The expenditures made to prepare for – or recover from – a pandemic.
Pandemic severity
Excess death attributable to a given influenza pandemic (expressed in this paper in standardized 
mortality units or SMUs - a unit of 1 per 10 000 per year).
Pandemic risk
The estimated probabilities that, in any given year, pandemics of varying degrees of severity 
will occur.
Expected annual losses
Defined in the probabilistic sense as the sum, across severities, of the losses associated with a 
pandemic of any given severity multiplied by the probability that a pandemic of that severity 
will occur in the coming year.
Note: Much of this nomenclature accords with that of the insurance industry.
 Bull World Health Organ 2018;96:129–134| doi: http://dx.doi.org/10.2471/BLT.17.199588
131
Policy & practice
Economic losses of pandemic risk
Victoria Y Fan et al.
Like other economic studies of 
pandemic influenza, we identified two 
main influenza pandemic scenarios in 
terms of aggregate mortality: moderate 
and severe. Our review classified the 
1918 pandemic as severe. As the world 
population in 1918 was about 1830 
million and historical data indicate that 
there were at least 20 million pandemic-
related deaths in that year, the excess 
death rate associated with the pandemic 
was at least 1.1%. A closer examination 
of the data from India indicate that the 
true global rate was probably far higher 
than 1.1%, the pandemic led to 14 mil-
lion deaths in India36–38 and it seems im-
plausible that India accounted for 73% 
of all of the pandemic-related deaths 
at a time when it had 18% of the world 
population. However, to be conserva-
tive, we estimated an expected annual 
excess mortality rate of 0.93 SMUs. In 
the corresponding model for moderate 
pandemics, we used a global expected 
excess mortality rate of 0.05 SMUs, as 
seen in historical moderate pandemics.39
Our calibration pointed to a very 
fat-tailed distribution.12 Thus, com-
pared with an exponential function, 
the hyperbolic family of complemen-
tary cumulative distributions provided 
more natural candidates for r(s). We 
parameterized the hyperbolic function 
in terms of its expectation and the fat-
ness of its tail.40 Thus:
r(s) = [1 + m(1 – f)s] 
– [1 + 1/(1 – 
f)] 
(2)
where f indicates the fatness of the tail, 
with smaller values implying a fatter 
tail. We estimate a value of f of -2. It had 
previously been estimated that, in 2015, 
a 1918-type pandemic would have killed 
21 million to 33 million people, with 
a return time of 100–200 years.35 Our 
models produced similar values. Recent 
estimates of influenza and pneumonia 
mortality18,31 are also consistent with our 
all-cause mortality estimates. Our esti-
mates are based on assumptions that are 
probably quite conservative. Substan-
tially greater severities and likelihoods 
have been discussed elsewhere.5,35,41,42
Mortality-inclusive value of 
losses
We used our estimated exceedance 
probability function and empirically 
estimated values for small changes in 
mortality risk to calculate the expected 
i.e. mortality-inclusive, value of losses 
associated with a moderate or severe 
influenza pandemic. At 2013 values, the 
expected losses for 2015 amounted to 
about 500 billion United States dollars 
(US$), i.e. about 0.6% of global income, 
per year.12 The estimated proportion of 
annual national income represented by 
the losses varied according to country 
income grouping, from a little over 
0.3% in high-income countries to 1.6% 
in lower-middle-income countries 
(Table 1).
The expected-loss framework dis-
tinguishes between the loss associated 
with a certain event that occurred, e.g. 
the mortality that occurred as a result 
of the 1918 influenza pandemic, and 
the expected loss associated with an 
uncertain event over a period of risk 
exposure. The expected loss combines 
both the risk of a moderate or severe 
pandemic and the losses from that event 
should the event occur. The expected-
loss framework thus produces estimates 
of expected losses of an uncertain event, 
rather than actual losses of a certainly 
occurring event. We estimated the 
expected number of pandemic-related 
deaths to be about 720 000 per year. This 
level of mortality is on a similar scale to 
that attributable to other, more certain, 
causes of death, including other major 
infectious causes of death.12
Importantly, we concluded that 
most of the expected loss from influenza 
pandemics results from extreme events. 
Another effort to estimate exceedance 
probability functions indicated that, 
among all pathogens that can cause a pan-
demic, influenza virus was likely to be the 
predominant cause of pandemic-related 
mortality.18 The implication is clear: any 
efforts at pandemic preparedness need 
to be most strongly focused on influenza 
and on preparation for a severe scenario.
Our results present losses much 
higher than those found in studies 
limited to income losses. Income 
losses have been estimated to represent 
around 15% and 50% of the total eco-
nomic losses associated with a severe 
pandemic and a mild pandemic, re-
spectively.5,11 In previous studies, across 
modelled pandemics of all severities, 
mean income losses were estimated to 
be US$ 80 billion per year5,11, i.e. about 
16% of our estimate of total pandemic-
related costs.
Climate change comparison
In terms of the percentage of global in-
come, our estimate of total pandemic-
related losses (0.6%) falls within the 
corresponding Intergovernmental Pan-
el on Climate Change’s estimates of the 
costs of global warming (0.2–2.0%).43 
However, the magnitude of future 
global warming and the associated 
economic losses are still uncertain.44,45 
The same is true for future pandemics. 
Many of the hundreds of studies on 
the potential costs of climate change46 
have been hampered by the wide varia-
tion in estimates of the so-called social 
cost of carbon.47 If this cost is set at 
about US$ 120 per tonne, the cost of 
the carbon dioxide emissions in 2013 
would have been about 1% of global in-
come.46,48 As in many previous attempts 
to estimate the economic losses associ-
ated with a pandemic, many previous 
attempts to estimate the social costs 
of carbon have focused on national 
income accounts, without any explicit 
valuation of the increases in mortality 
resulting from climate change. The 
mortality-associated costs of climate 
change may be relatively small, how-
ever, since the slowness of climate 
change should allow for compensatory 
human adaptation.
Table 1. Mortality and economic losses of influenza-pandemic risk, 2015
Variablea
Country income group
World
Low
Lower-middle
Upper-middle
High
Expected mortality 
(thousands of 
deaths/year)
120
390
180
28
720
Expected annual 
economic losses (% 
of GNI/year)b
1.1
1.6
1.0
0.3
0.6
GNI: gross national income.
a  Data are based on modelled risk of either a moderate or severe pandemic in 2015.12
b  Both loss of national income and intrinsic loss associated with elevated mortality.
 Bull World Health Organ 2018;96:129–134| doi: http://dx.doi.org/10.2471/BLT.17.199588
132
Policy & practice
Economic losses of pandemic risk
Victoria Y Fan et al.
Limitations
Our study had several limitations. 
First, we ignored the intrinsic un-
desirability of nonfatal illness and/
or pandemic fear. Intense media 
coverage may lead populations to 
overreact to mild pandemics. Second, 
our estimates of future pandemic risk 
and severity, and the economic esti-
mates based on these epidemiological 
estimates, are relatively crude partly 
because pandemics remain rare and 
uncertain events. Future modelling 
should lead to improved estimates 
over time. Third, the assignment of 
monetary value to small changes in 
mortality risk and, particularly the 
relationship between valuation of such 
risk and both individual income and 
age at death, remains controversial. 
However, the results of sensitivity 
analyses, in which we applied a range 
of assumptions on these parameters, 
indicated that our main findings were 
reasonably robust.
Policy development
In addition to pathogens of pandemic 
potential, an expected-loss framework 
may also be applied usefully to malaria 
and other diseases that have fluctuating 
incidence. As cases of the disease become 
rarer as the result of effective interven-
tions, malaria becomes less visible politi-
cally and financially, and policy-makers 
in some countries may have responded 
by reducing control efforts prematurely. 
Policy-makers, and the societies they 
serve, could benefit by using an expect-
ed-loss framework to estimate the losses 
associated with uncertain and rare events 
across the full range of potential outcome 
severities. This could lead to appropri-
ate and beneficial adjustments to each 
policy-maker’s sense of risk and sense of 
value and to improved national policies 
on epidemic and pandemic prepared-
ness. A recent United States National 
Academy of Medicine report argued 
that, given the risks we estimated, policy 
attention has fallen short.49,50 National 
efforts at pandemic preparedness have 
benefits beyond national borders. Some 
have therefore argued that, for the 
global good, resources for development 
assistance should be used to provide 
incentives for national investments and 
international collaborations in such 
preparedness.3 ■
Acknowledgements
We thank Peter Sands and Bradley 
Chen. VYF has a secondary appoint-
ment with Harvard T H Chan School 
of Public Health, Boston, United States 
of America.
Funding: VYF was supported by a grant 
(#5U54MD007584) from the National 
Institute on Minority Health and Health 
Disparities, a component of the United 
States National Institutes of Health. DTJ 
was supported by the Bill & Melinda 
Gates Foundation via a grant to the Uni-
versity of Washington. 
Competing interests: None declared.
صخلم
؟ةعقوتلما رئاسلخا ةحادف لصت ىدم يأ لىإ :ةئبولأا راشتنا رطخ
 لىإ فديه يذلا رماثتسلاا ةدايز لىإ ةجالحا ةيبلت في زجع دجوي
 دقو .راشتنلاا ةعساو ةيسيئرلا ضارملأاو ةئبولأا ةهجاولم بهأتلا
 تاريدقت لىإ يربك لكشب رماثتسلاا اذله ةديؤلما ججلحا تدنتسا
 ضارملأا وأ ةئبولأل ةجيتن عقت دق يتلاو يموقلا لخدلا في رئاسلخا
 ًماييقت لمشيل انتاريدقت قاطن عستاو .راشتنلاا ةعساو ةيسيئرلا
 في رئاسخ نم ةئبولأاب ةطبترلما تايفولا دادعأ عافترا نع جتن الم
 ةميقلا تاريدقت في ظوحلم عافترا كلذ نع جتن دقو .حاورلأا
 انمق دقو .ليبقتسم ءابو روهظ ةجيتن عقت دق يتلا رئاسخلل ةلماكلا
 ءابوب قلعتي مايف زواجتلا تلاماتحا ةلادل ةيسايق تلاماعم عضوب
 نأ لىإ تاريدقتلا تراشأو ،لماعلا ىوتسم لىع شيفتلما ازنولفنلإا
 لياوح غلبي ازنولفنلإا ءابو شيفت نع ةجمانلا تايفولل عقوتلما ددعلا
 لىإ ،انتاباسلح اًقفو ،تاعقوتلا تراشأو .ماعلا في ةمسن 000 720
 500 لياوح غلبت ةيونس رئاسخ عوقوب ددته ةيشفتلما ضارملأا نأ
 ماعلا في – يلماعلا لخدلا نم 0.6% وأ – يكيرمأ رلاود رايلم
 ام نمض – ميقلا لقأ نع برعي يذلا – ريدقتلا اذه جردنيو .دحاولا
 تاريدقت نم خانلما يرغتب ةينعلما ةيلودلا ةيموكلحا ةئيلها هيلإ تلصوت
 اهتبسن حواترت يتلاو ،يرارلحا سابتحلاا نع ةجمانلا رئاسلخا ةميقل
 لخدلل ةردقلما ةيوئلما ةبسنلا نإ .يلماعلا لخدلا نم 2%و 0.2% ينب
 اًقفو نيابتت رئاسخلل ةعقوتلما ةميقلا اهلثتم يتلاو يونسلا يموقلا
 في 0.3% نع ًلايلق ديزت ةبسن نم :لخدلا بسح لودلا فينصتل
 لودلا نم ىندلأا ةيحشرلا في 1.6% ةبسن لىإ لخدلا ةيلاع لودلا
 ازنولفنلإا ةئبوأ نع ةجمانلا رئاسلخا مظعم عقتو .لخدلا ةطسوتم
.ةداحو ةردان ةيضرم تلااح دوجو ةجيتن
摘要
大流行风险 ：
预期损失有多大？
在应对重大流行病和大流行病方面，需要更多的投
资。支持此类投资主要是基于对国民收入损失的估
计，这些损失可能投入到主要流行或大流行病。最
近，我们扩大了估计范围，包括因大流行病相关导致
的死亡率增加而丧失的生命估值。这大大提高了对可
能发生的损失价值全额的估计，这可能用于未来大流
行病。我们对全球流感大流行的超过概率函数进行了
参数化，并估计流感大流行导致的相关死亡人数每
年约为 72 万人。我们计算出，每年的流感大流行损
失预计将达到约 5000 亿美元——或占每年全球收入
的 0.6%。这一估计属于政府间气候变化专门委员会对
全球变暖造成的损失估计，但接近于较低端，全球变
暖造成的损失占全球收入的 0.2% 到 2%。按国家收入
分组计算的损失预期值所代表的年度国民收入的百分
比 ：
从高收入国家的略高于 0.3% 到低中等收入国家
的 1.6%。流感大流行造成的大部分损失都来自罕见的
严重事件。
 Bull World Health Organ 2018;96:129–134| doi: http://dx.doi.org/10.2471/BLT.17.199588
133
Policy & practice
Economic losses of pandemic risk
Victoria Y Fan et al.
Résumé
Risque de pandémie: quelle est l’ampleur des pertes escomptées?
Il est nécessaire d’investir davantage dans la préparation contre les 
grandes épidémies et les pandémies. Les arguments en faveur de 
cet investissement s’appuient en grande partie sur les estimations 
des pertes au niveau du revenu national que pourrait entraîner une 
grande épidémie ou une pandémie. Récemment, nous avons élargi ces 
estimations pour y inclure la valeur des pertes faisant suite à des hausses 
de mortalité dues à des pandémies. Cela a donné des estimations 
nettement plus élevées de la valeur totale de la perte que pourrait 
occasionner une future pandémie. Nous avons paramétré une fonction 
de probabilité de dépassement pour une pandémie mondiale de grippe 
et avons estimé que le nombre escompté de décès dus à cette pandémie 
de grippe était d’environ 720 000 par an. Nous avons calculé que les 
pertes annuelles découlant du risque de pandémie représentaient 
environ 500 milliards de dollars des États-Unis, soit 0,6% du revenu 
mondial par an. Cette estimation rejoint (dans la fourchette inférieure) 
celles du Groupe d’experts intergouvernemental sur l’évolution du climat 
quant à la valeur des pertes dues au réchauffement de la planète, qui 
vont de 0,2% à 2% du revenu mondial. Le pourcentage estimé du revenu 
national annuel représenté par la valeur escomptée des pertes variait 
selon la catégorie de revenu des pays: d’un peu plus de 0,3% dans les 
pays à revenu élevé à 1,6% dans les pays à revenu intermédiaire-tranche 
inférieure. La plupart des pertes découlant de pandémies de grippe sont 
dues à des événements rares et graves.
Резюме
Пандемический риск: насколько велики возможные потери
Требуется увеличение инвестиций в подготовку к борьбе с 
крупными эпидемиями и пандемиями. Аргументы в пользу таких 
инвестиций в значительной степени основаны на оценках потерь 
в национальном доходе, которые могут возникнуть в результате 
крупной эпидемии или пандемии. Недавно авторы расширили 
эту оценку, включив в нее количество людей, погибших в 
результате увеличения смертности, связанной с пандемией. 
Это привело к более высоким оценкам полного ущерба, 
который может возникнуть в результате будущей пандемии. 
Авторы параметризовали функцию вероятности превышения 
смертности для глобальной пандемии гриппа и подсчитали, 
что прогнозируемое число смертей от гриппа и пандемии 
составляет около 720 000 в год. Мы подсчитали, что ожидаемые 
ежегодные потери из-за риска пандемии составляют около 
500 млрд долларов США (или 0,6% мирового дохода) в год. Эта 
цифра находится в пределах оценки (ближе к нижней границе), 
полученной Межправительственной группой экспертов по 
изменению климата для оценки риска глобального изменения 
климата, которая составляет от 0,2 до 2% от глобального дохода. 
Предполагаемый процент годового национального дохода, 
представленный ожидаемой величиной потерь, варьировался 
по группам стран в зависимости от уровня дохода: от немногим 
более 0,3% в странах с высоким уровнем доходов до 1,6% в 
странах с низкими и средним доходом. Большинство потерь 
от пандемии гриппа происходят по причине редких тяжелых 
явлений.
Resumen
Riesgo de pandemia: ¿cuán grandes son las pérdidas esperadas?
Hay una necesidad no satisfecha de invertir más en la preparación para 
grandes epidemias y pandemias. Los argumentos a favor de dicha 
inversión se basan, en gran parte, en las estimaciones de las pérdidas 
en los ingresos nacionales que podrían darse como resultado de una 
gran epidemia o pandemia. Recientemente, ampliamos el cálculo para 
incluir la valoración de las vidas perdidas como resultado del aumento 
de la mortalidad relacionado con la pandemia. Esto dio como resultado 
unas estimaciones notablemente más altas del valor de la pérdida que 
podría resultar de una futura pandemia. Hemos parametrizado una 
función de probabilidad de excedencia para una pandemia de gripe 
mundial y estimado que el número esperado de muertes causadas 
por una pandemia de gripe es de aproximadamente 720 000 por 
año. Calculamos que las pérdidas anuales esperadas del riesgo de 
pandemia son de unos 500 000 millones de dólares estadounidenses, 
o el 0,6 % de los ingresos mundiales, por año. Esta estimación se 
encuentra dentro, pero cerca del mínimo, de las estimaciones del Panel 
Intergubernamental del Cambio Climático sobre el valor de las pérdidas 
por el calentamiento global, que oscilan entre el 0,2 % y el 2 % de los 
ingresos globales. El porcentaje estimado de los ingresos nacionales 
anuales representado por el valor esperado de las pérdidas varió según 
la agrupación de ingresos del país: de poco más del 0,3 % en los países 
con ingresos altos al 1,6 % en los países con ingresos medios o bajos. 
La mayoría de las pérdidas por pandemias de gripe provienen de casos 
raros y severos.
References
1. 
Sands P, El Turabi A, Saynisch PA, Dzau VJ. Assessment of economic vulnerability 
to infectious disease crises. Lancet. 2016 11 12;388(10058):2443–8. doi: http://
dx.doi.org/10.1016/S0140-6736(16)30594-3 PMID: 27212427
2. 
From panic and neglect to investing in health security: financing pandemic 
preparedness at a national level. Washington: World Bank Group; 2017. Available 
from: http://documents.worldbank.org/curated/en/979591495652724770/
pdf/115271-REVISED-PUBLIC-IWG-Report-Conference-Edition-8-10-2017-low-
res.pdf [cited 2017 Nov 24].
3. 
Yamey G, Schäferhoff M, Aars OK, Bloom B, Carroll D, Chawla M, et al. Financing 
of international collective action for epidemic and pandemic preparedness. 
Lancet Glob Health. 2017 Aug;5(8):e742–4. doi: http://dx.doi.org/10.1016/
S2214-109X(17)30203-6 PMID: 28528866
4. 
Peters DH, Keusch GT, Cooper J, Davis S, Lundgren J, Mello MM, et al. In 
search of global governance for research in epidemics. Lancet. 2017 Oct 
7;390(10103):1632–3. doi: http://dx.doi.org/10.1016/S0140-6736(17)32546-1 
PMID: 29131784
5. 
McKibbin W, Sidorenko A. Global macroeconomic consequences of pandemic 
influenza. Sydney: Lowy Institute for International Policy; 2006. Available from: 
https://www.brookings.edu/wp-content/uploads/2016/06/200602.pdf [cited 
2017 Nov 24].
6. 
Meltzer MI, Cox NJ, Fukuda K. The economic impact of pandemic influenza 
in the United States: priorities for intervention. Emerg Infect Dis. 1999 
Sep-Oct;5(5):659–71. doi: http://dx.doi.org/10.3201/eid0505.990507 PMID: 
10511522
 Bull World Health Organ 2018;96:129–134| doi: http://dx.doi.org/10.2471/BLT.17.199588
134
Policy & practice
Economic losses of pandemic risk
Victoria Y Fan et al.
7. 
Prager F, Wei D, Rose A. Total economic consequences of an influenza outbreak 
in the United States. Risk Anal. 2017 Jan;37(1):4–19. doi: http://dx.doi.
org/10.1111/risa.12625 PMID: 27214756
8. 
Liu J-T, Hammitt JK, Wang J-D, Tsou M-W. Valuation of the risk of SARS in Taiwan. 
Health Econ. 2005 Jan;14(1):83–91. doi: http://dx.doi.org/10.1002/hec.911 
PMID: 15386665
9. 
Brahmbhatt M, Dutta A. On SARS type economic effects during infectious 
disease outbreaks. Washington: World Bank; 2008. Available from: http://
documents.worldbank.org/curated/en/101511468028867410/pdf/wps4466.
pdf [cited 2017 Nov 24]. doi: http://dx.doi.org/10.1596/1813-9450-4466 doi: 
http://dx.doi.org/10.1596/1813-9450-4466
10. Jonas OB. Pandemic risk. Washington: World Bank; 2013. Available from: 
https://openknowledge.worldbank.org/bitstream/handle/10986/16343/
WDR14_bp_Pandemic_Risk_Jonas.pdf?sequence=1&isAllowed=y [cited 2015 
Oct 21].
11. Burns A, Mensbrugghe D, Timmer H. Evaluating the economic consequences 
of avian influenza. Washington: World Bank; 2008. Available from: http://
documents.worldbank.org/curated/en/977141468158986545/pdf/474170WP0
Evalu101PUBLIC10Box334133B.pdf [cited 2015 Mar 24].
12. Fan VY, Jamison DT, Summers LH. The loss from pandemic influenza risk. In: 
Jamison DT, Gelband H, Horton S, Jha P, Laxminarayan R, Mock CN, et al., editors. 
Disease control priorities. 3rd ed. Volume 9. Washington: World Bank; 2018: 
347-358.
13. The cost of air pollution. Health impacts of road transport [internet]. Paris: 
Organisation for Economic Co-operation and Development; 2014. Available 
from: http://www.oecd-ilibrary.org/content/book/9789264210448-en [cited 
2016 Apr 2].
14. Lindhjem H, Navrud S, Braathen NA, Biausque V. Valuing mortality risk 
reductions from environmental, transport, and health policies: a global meta-
analysis of stated preference studies. Risk Anal. 2011 Sep;31(9):1381–407. doi: 
http://dx.doi.org/10.1111/j.1539-6924.2011.01694.x PMID: 21957946
15. Jamison DT, Summers LH, Alleyne G, Arrow KJ, Berkley S, Binagwaho A, et al. 
Global health 2035: a world converging within a generation. Lancet. 2013 Dec 
7;382(9908):1898–955. doi: http://dx.doi.org/10.1016/S0140-6736(13)62105-4 
PMID: 24309475
16. Hammitt JK, Robinson LA. The income elasticity of the value per statistical life: 
transferring estimates between high and low income populations. J Benefit 
Cost Anal. 2011 Jan;2(1):1–29. doi: http://dx.doi.org/10.2202/2152-2812.1009
17. The AIR pandemic flu model [internet]. Boston: AIR Worldwide; 2016. Available 
from: http://www.air-worldwide.com/Publications/AIR-Currents/2014/The-AIR-
Pandemic-Flu-Model/ [cited 2016 Feb 28].
18. Madhav N, Oppenheim B, Gallivan M, Mulembakani P
, Rubin E, Wolfe N. 
Pandemics: risks, impacts, and mitigation. In: Jamison DT, Gelband H, Horton S, 
Jha P, Laxminarayan R, Mock CN, et al., editors. Disease control priorities. 3rd ed. 
Volume 9. Washington: World Bank; 2018: 315-345.
19. Molinari N-AM, Ortega-Sanchez IR, Messonnier ML, Thompson WW, Wortley PM, 
Weintraub E, et al. The annual impact of seasonal influenza in the US: measuring 
disease burden and costs. Vaccine. 2007 Jun 28;25(27):5086–96. doi: http://
dx.doi.org/10.1016/j.vaccine.2007.03.046 PMID: 17544181
20. Keren R, Zaoutis TE, Saddlemire S, Luan XQ, Coffin SE. Direct medical cost of 
influenza-related hospitalizations in children. Pediatrics. 2006 Nov;118(5):e1321–7. 
doi: http://dx.doi.org/10.1542/peds.2006-0598 PMID: 17079533
21. Schoenbaum SC. Economic impact of influenza. The individual’s perspective. 
Am J Med. 1987 Jun 19;82(6A) Supplement 1:26–30. doi: http://dx.doi.
org/10.1016/0002-9343(87)90557-2 PMID: 3109239
22. Akazawa M, Sindelar JL, Paltiel AD. Economic costs of influenza-related work 
absenteeism. Value Health. 2003 Mar-Apr;6(2):107–15. doi: http://dx.doi.
org/10.1046/j.1524-4733.2003.00209.x PMID: 12641861
23. Simmerman JM, Lertiendumrong J, Dowell SF, Uyeki T, Olsen SJ, Chittaganpitch 
M, et al. The cost of influenza in Thailand. Vaccine. 2006 May 15;24(20):4417–26. 
doi: http://dx.doi.org/10.1016/j.vaccine.2005.12.060 PMID: 16621187
24. Keogh-Brown MR, Smith RD, Edmunds JW, Beutels P
. The macroeconomic 
impact of pandemic influenza: estimates from models of the United Kingdom, 
France, Belgium and The Netherlands. Eur J Health Econ. 2010 Dec;11(6):543–
54. doi: http://dx.doi.org/10.1007/s10198-009-0210-1 PMID: 19997956
25. Keogh-Brown MR, Wren-Lewis S, Edmunds WJ, Beutels P, Smith RD. The possible 
macroeconomic impact on the UK of an influenza pandemic. Health Econ. 2010 
Nov;19(11):1345–60. doi: http://dx.doi.org/10.1002/hec.1554 PMID: 19816886
26. Peasah SK, Azziz-Baumgartner E, Breese J, Meltzer MI, Widdowson MA. Influenza 
cost and cost-effectiveness studies globally–a review. Vaccine. 2013 Nov 
4;31(46):5339–48. doi: http://dx.doi.org/10.1016/j.vaccine.2013.09.013 PMID: 
24055351
27. Kip Viscusi W. The value of individual and societal risks to life and health. 
In: Machina M, Viscusi WK, editors. Handbook of the economics of risk and 
uncertainty. Amsterdam: North-Holland; 2014. p. 385–452. doi: http://dx.doi.
org/10.1016/B978-0-444-53685-3.00007-6
28. Ozawa S, Stack ML, Bishai DM, Mirelman A, Friberg IK, Niessen L, et al. During 
the ‘decade of vaccines,’ the lives of 6.4 million children valued at $231 billion 
could be saved. Health Aff (Millwood). 2011 Jun;30(6):1010–20. doi: http://
dx.doi.org/10.1377/hlthaff.2011.0381 PMID: 21653951
29. Watkins D, Daskalakis A. The economic impact of rheumatic heart disease 
in developing countries. Lancet Glob Health. 2015;3:S37. doi: http://dx.doi.
org/10.1016/S2214-109X(15)70156-7
30. Ebola situation report – 16 March 2016. Geneva: World Health Organization; 
2016. Available from: http://apps.who.int/iris/bitstream/10665/204629/1/
ebolasitrep_16Mar2016_eng.pdf?ua=1 [cited 2016 Apr 2].
31. Taubenberger JK, Morens DM, Fauci AS. The next influenza pandemic: can it be 
predicted? JAMA. 2007 May 9;297(18):2025–7. doi: http://dx.doi.org/10.1001/
jama.297.18.2025 PMID: 17488968
32. Potter CW. A history of influenza. J Appl Microbiol. 2001 Oct;91(4):572–9. doi: 
http://dx.doi.org/10.1046/j.1365-2672.2001.01492.x PMID: 11576290
33. Beveridge WI. The chronicle of influenza epidemics. Hist Philos Life Sci. 
1991;13(2):223–34. PMID: 1724803
34. Ghendon Y. Introduction to pandemic influenza through history. Eur J 
Epidemiol. 1994 Aug;10(4):451–3. doi: http://dx.doi.org/10.1007/BF01719673 
PMID: 7843353
35. Madhav N. Modelling a modern-day Spanish flu pandemic [internet]. 
Boston: AIR Worldwide; 2013. Available from: http://www.air-worldwide.
com/publications/air-currents/2013/modeling-a-modern-day-spanish-flu-
pandemic/ [cited 2017 Nov 24].
36. Davis K. The population of India and Pakistan. New York: Russell & Russell; 1968.
37. Hill K. Influenza in India 1918: excess mortality reassessed. Genus. 2011;67(2):9–29.
38. Murray CJL, Lopez AD, Chin B, Feehan D, Hill KH. Estimation of potential global 
pandemic influenza mortality on the basis of vital registry data from the 1918-
20 pandemic: a quantitative analysis. Lancet. 2006 Dec 23;368(9554):2211–8. 
doi: http://dx.doi.org/10.1016/S0140-6736(06)69895-4 PMID: 17189032
39. Luk J, Gross P
, Thompson WW. Observations on mortality during the 1918 
influenza pandemic. Clin Infect Dis. 2001 Oct 15;33(8):1375–8. doi: http://dx.doi.
org/10.1086/322662 PMID: 11565078
40. Jamison DT, Jamison J. Characterizing the amount and speed of discounting 
procedures. J Benefit Cost Anal. 2011 Jan 25;2(2):1–53. doi: http://dx.doi.
org/10.2202/2152-2812.1031
41. Bruine De Bruin W, Fischhoff B, Brilliant L, Caruso D. Expert judgments of 
pandemic influenza risks. Glob Public Health. 2006;1(2):178–93. doi: http://
dx.doi.org/10.1080/17441690600673940 PMID: 19153906
42. Osterholm MT. Preparing for the next pandemic. N Engl J Med. 2005 May 
5;352(18):1839–42. doi: http://dx.doi.org/10.1056/NEJMp058068 PMID: 
15872196
43. Core Writing Team. Pachauri RK, Meyer LA, editors. Climate Change 2014: 
Synthesis Report. Geneva: Intergovernmental Panel on Climate Change; 
2014. Available from: http://www.ipcc.ch/pdf/assessment-report/ar5/syr/
SYR_AR5_FINAL_full_wcover.pdf [cited 2017 Nov 24].
44. Moore FC, Diaz DB. Temperature impacts on economic growth warrant 
stringent mitigation policy. Nat Clim Chang. 2015 Jan 12;5(2):127–31. doi: 
http://dx.doi.org/10.1038/nclimate2481
45. Valuing climate damages. Updating estimation of the social cost of carbon 
dioxide. Washington: National Academies Press; 2017.
46. Tol RSJ. Climate change. CO2 abatement. In: Lomborg B, editor. Global 
problems, smart solutions: costs and benefits. Cambridge: Cambridge University 
Press; 2013.
47. Pizer W, Adler M, Aldy J, Anthoff D, Cropper M, Gillingham K, et al. Environmental 
economics. Using and improving the social cost of carbon. Science. 2014 Dec 
5;346(6214):1189–90. doi: http://dx.doi.org/10.1126/science.1259774 PMID: 
25477446
48. Nordhaus WD. Economic aspects of global warming in a post-Copenhagen 
environment. Proc Natl Acad Sci USA. 2010 Jun 29;107(26):11721–6. doi: http://
dx.doi.org/10.1073/pnas.1005985107 PMID: 20547856
49. The neglected dimension of global security: a framework to counter infectious 
disease crises. Washington: National Academies Press; 2016.
50. Sands P
, Mundaca-Shah C, Dzau VJ. The neglected dimension of global security 
— a framework for countering infectious-disease crises. N Engl J Med. 2016 
Mar 31;374(13):1281–7. doi: http://dx.doi.org/10.1056/NEJMsr1600236 PMID: 
26761419
